This report contains market size and forecasts of Ultra Short Acting Anesthetic in global, including the following market information:
Global Ultra Short Acting Anesthetic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ultra Short Acting Anesthetic Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Ultra Short Acting Anesthetic companies in 2021 (%)
The global Ultra Short Acting Anesthetic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Methitural Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ultra Short Acting Anesthetic include Paion, AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare and Hikma Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ultra Short Acting Anesthetic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ultra Short Acting Anesthetic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Anesthetic Market Segment Percentages, by Type, 2021 (%)
Methitural
Byfavo
Methohexital
Thiamylal
Thiopental
Propofol
Global Ultra Short Acting Anesthetic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Anesthetic Market Segment Percentages, by Application, 2021 (%)
Hospital Use
Clinic Use
Others
Global Ultra Short Acting Anesthetic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Anesthetic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ultra Short Acting Anesthetic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ultra Short Acting Anesthetic revenues share in global market, 2021 (%)
Key companies Ultra Short Acting Anesthetic sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Ultra Short Acting Anesthetic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Paion
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Pfizer
Merck
Eli Lilly
Meda pharmaceuticals
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals